Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 6.77 is 42% above its 5-year average of 4.78, near the low end of its 5-year range (0.67–42.97).
As of the fiscal period ended Tuesday, June 30, 2026. 90.77% above its 12-month average of 3.55.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.77.
QUICK RATIO (ACID-TEST)
6.77
QUICK RATIO (ACID-TEST) AVG TTM
3.55
QUICK RATIO (ACID-TEST) AVG 3Y
2.29
QUICK RATIO (ACID-TEST) AVG 5Y
4.78
QUICK RATIO (ACID-TEST) AVG 10Y
9.98
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+90.77%
CURRENT VS 3Y AVG
+195.79%
CURRENT VS 5Y AVG
+41.60%
CURRENT VS 10Y AVG
-32.19%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.15
median of 697 covered companies
CURRENT VS SECTOR MEDIAN
+114.76%
vs the sector median at left
Market Cap
$1.38M
Quick Ratio (Acid-Test)
3.00
TTM Avg
0.80
3Y Avg
7.12
5Y Avg
9.62
Market Cap
$1.46M
Quick Ratio (Acid-Test)
0.67
TTM Avg
0.15
3Y Avg
0.14
5Y Avg
1.64
Market Cap
$1.46M
Quick Ratio (Acid-Test)
7.70
TTM Avg
0.13
3Y Avg
0.13
5Y Avg
0.13
Market Cap
$1.49M
Quick Ratio (Acid-Test)
1.30
TTM Avg
2.54
3Y Avg
2.69
5Y Avg
2.23
Market Cap
$1.21M
Quick Ratio (Acid-Test)
0.62
TTM Avg
1.47
3Y Avg
0.74
5Y Avg
0.53
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Genprex, Inc. (GNPX) | $1.37M | 6.77 | 3.55 | 2.29 | 4.78 |
| NewcelX Ltd. (NCEL)vs › | $1.36M | 0.32 | 1.73 | 1.61 | 1.48 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | 3.00 | 0.80 | 7.12 | 9.62 |
| NEXGEL, Inc. (NXGL)vs › | $1.40M | 0.27 | 1.06 | 2.93 | 2.76 |
| INVO Fertility, Inc. (IVF)vs › | $1.46M | 0.67 | 0.15 | 0.14 | 1.64 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | 7.70 | 0.13 | 0.13 | 0.13 |
| Curis, Inc. (CRIS)vs › | $1.48M | 0.49 | 0.94 | 3.46 | 6.68 |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | 1.30 | 2.54 | 2.69 | 2.23 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.21M | 0.62 | 1.47 | 0.74 | 0.53 |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.17M | 2.55 | 2.02 | 1.02 | 0.68 |
Quick Ratio
6.77
Excludes inventory
Current Ratio
6.77
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 6.77 |
| 2026-03-31 | 5.61 |
| 2025-12-31 | 3.84 |
| 2025-09-30 | 0.67 |
| 2025-06-30 | 0.84 |
| 2025-03-31 | 1.94 |
| 2024-12-31 | 0.83 |
| 2024-09-30 | 0.86 |
| 2024-06-30 | 1.95 |
| 2024-03-31 | 2.42 |
| 2023-12-31 | 2.31 |
| 2023-09-30 | 2.96 |
| 2023-06-30 | 3.20 |
| 2023-03-31 | 4.12 |
| 2022-12-31 | 7.64 |
| 2022-09-30 | 10.71 |
| 2022-06-30 | 14.35 |
| 2022-03-31 | 14.97 |
| 2021-12-31 | 24.69 |
| 2021-09-30 | 36.81 |
| 2021-06-30 | 42.97 |
| 2021-03-31 | 82.10 |
| 2020-12-31 | 61.47 |
| 2020-09-30 | 58.63 |
| 2020-06-30 | 97.02 |
| 2020-03-31 | 34.47 |
| 2019-12-31 | 4.26 |
| 2019-09-30 | 5.23 |
| 2019-06-30 | 5.71 |
| 2019-03-31 | 30.49 |
| 2018-12-31 | 22.81 |
| 2018-09-30 | 18.91 |
| 2018-06-30 | 41.73 |
| 2018-03-31 | 0.04 |
| 2017-12-31 | 0.23 |
| 2017-09-30 | 1.01 |
| 2017-06-30 | 2.36 |
| 2017-03-31 | 5.63 |
| 2016-12-31 | 5.77 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
